Actively Recruiting
Home Monitoring During Chemoradiation
Led by University Medical Center Groningen · Updated on 2025-08-14
30
Participants Needed
1
Research Sites
72 weeks
Total Duration
On this page
Sponsors
U
University Medical Center Groningen
Lead Sponsor
S
Siemens Corporation, Corporate Technology
Collaborating Sponsor
AI-Summary
What this Trial Is About
Chemoradiotherapy is part of standard treatment for patients with locally advanced oesophageal cancer. Some patients with oesophageal cancer treated with chemoradiotherapy do not complete treatment due to toxicity, or face complications after treatment. Therefore, there is a need for better tools for assessing patients' fitness for chemoradiotherapy and to pick up early signals of deteriorating overall physical condition and complications during and after treatment to timely implement supportive care measures. Tools enabling monitoring physical activity, vital parameters and creatinine concentration in the blood at home are available but have not yet been implemented in patients undergoing chemoradiotherapy for oesophageal cancer. The feasibility and added value remain unknown.
CONDITIONS
Official Title
Home Monitoring During Chemoradiation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older at the time of signing informed consent
- Histologically proven adenocarcinoma, squamous cell carcinoma, or mixed type of the oesophagus or gastro-oesophageal junction
- Indication for definitive or neoadjuvant chemoradiotherapy with weekly carboplatin and paclitaxel
- Written informed consent
- Ability to comply with all protocol-required actions, including performing home measurements independently
You will not qualify if you...
- Altered mental status or any psychiatric condition that would prevent understanding or giving informed consent or performing home measurements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Medical Center Groningen
Groningen, Netherlands, 9713 GZ
Actively Recruiting
Research Team
R
Rudolf S.N. Fehrmann, MD, PhD
CONTACT
S
Sjoukje F. Oosting, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here